Seres Therapeutics, Inc.

MCRB · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 66 employees
185
SEC Filings
$3.62
Close 2026-09-24
66
Employees

Business Summary

Seres Therapeutics is a clinical-stage biopharmaceutical company developing live biotherapeutic products (LBPs) targeting diseases modulated by the human microbiome. It led development of VOWST, the first FDA-approved oral microbiome biotherapeutic, sold to Nestlé Health Science in September 2024. Its pipeline includes SER-155 (bloodstream infections, irEC), SER-603 (IBD), and SER-147 (chronic liver disease), all orally delivered bacterial consortia targeting mucosal barrier-immune interface pathways.

Latest Stock Quote

MCRB 2026-09-24 $3.62 O:$3.71 H:$3.85 L:$3.52 Vol:0.1M VWAP:$3.6333
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001193125-26-103276EDGAR108K words
2025-03-132024-12-310000950170-25-038427EDGAR106K words
2024-03-052023-12-310000950170-24-025464EDGAR115K words
2023-03-072022-12-310000950170-23-006374EDGAR108K words
2022-03-012021-12-310000950170-22-002435EDGAR113K words
2021-03-022020-12-310001564590-21-010057EDGAR102K words
2020-03-022019-12-310001564590-20-008002EDGAR109K words
2019-03-062018-12-310001564590-19-006423EDGAR93K words
2018-03-082017-12-310001564590-18-004830EDGAR92K words
2017-03-162016-12-310001564590-17-004551EDGAR101K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-052026-06-300001193125-26-334174EDGAR65K words
2025-11-052025-09-300001193125-25-266011EDGAR67K words
2025-08-062025-06-300000950170-25-103611EDGAR66K words
2025-05-072025-03-310000950170-25-065173EDGAR62K words
2024-11-132024-09-300000950170-24-126018EDGAR67K words
2024-08-132024-06-300000950170-24-095821EDGAR83K words
2024-05-082024-03-310000950170-24-055159EDGAR71K words
2023-11-022023-09-300000950170-23-057805EDGAR71K words
2023-08-082023-06-300000950170-23-039439EDGAR70K words
2023-05-092023-03-310000950170-23-019222EDGAR63K words
2022-11-022022-09-300000950170-22-021018EDGAR65K words
2022-08-032022-06-300000950170-22-014052EDGAR63K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-050001193125-26-333820EDGAR4K words
2026-08-040001193125-26-332742EDGAR6K words
2026-03-160001193125-26-108482EDGAR1K words
2026-03-120001193125-26-103034EDGAR4K words
2026-03-020001193125-26-085368EDGAR11K words
2025-11-050001193125-25-265708EDGAR4K words
2025-10-030001193125-25-230118EDGAR1K words
2025-08-060001193125-25-173985EDGAR4K words
2025-07-220001193125-25-162552EDGAR1K words
2025-05-070001193125-25-114430EDGAR4K words

185 total filings indexed. 153 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

infectious-disease-/-antimicrobial-resistance hematopoietic-stem-cell-transplantation inflammatory-and-immune-diseases inflammatory-bowel-disease immune-checkpoint-inhibitor-toxicity chronic-liver-disease oncology-/-cancer-supportive-care intensive-care-/-long-term-acute-care good-manufacturing-practices-(gmp) fast-track-designation breakthrough-therapy-designation

Company Identity

CIK0001609809
TickerMCRB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.serestherapeutics.com
Listed2015-06-26

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: fcb41bafbf1d58396d215eba84d95f003c93799781701421a515cec867bb6860
parent: 68fd2c10f58e873397ffdc4d015199564e4a7e037df104f6440b85d724d3f7eb
content hash: 3f193aab497686480dd15ba6008e906e5c8eecc38f8767f2ba6b153fc27f7a25
signed: 2026-10-13T19:02:14.445Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up MCRB using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on MCRB, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/MCRB (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.